Orphan drug status granted to sirolimus
OSN SuperSite
The US Food and Drug Administration granted orphan drug designation to sirolimus (DE-109) for the treatment of chronic/refractory anterior noninfectious uveitis, noninfectious intermediate uveitis, noninfectious panuveitis and noninfectious uveitis ...
Santen Sirolimus drug secures FDA orphan drug statusPharmaceutical Business Review
Santen Announces FDA Orphan Drug Status for Sirolimus (DE-109)istockAnalyst.com (press release)

all 5 news articles »